Kathryn Miles is a Senior Analyst with a particular interest in pharmaceuticals at the NIHR Horizon Scanning Centre (HSC). She currently jointly leads engagement with pharmaceutical companies to identify significant developments likely to have an impact on the NHS in the next three years. In addition, she manages liaison with the National Institute for Health and Care Excellence (NICE) topic selection programme.
Since 2012, Kathryn has jointly led the HSC Patient and Public Involvement and Engagement (PPI) strategy, presenting findings at HTAi conference in Washington 2014 and NIHR INVOLVE conference 2014.
As part of her pharmaceutical work, Kathryn carried out research into emerging orphan drugs, presenting her findings at HTAi conference in Rome in 2005, with final publication in QJM in 2007. More recently, she has worked on a review of biomarkers in development for Alzheimer's disease presented by poster at HTAi conference Bilbao in 2012. During her time at NIHR HSC, Kathryn has completed a Masters in Public Health.
Other professional research interests include the impact of gardening on health and wellbeing.